Stockscreener 앱 받기
0.53
1.40%
0.0073
전일 마감가:
$0.5227
열려 있는:
$0.5144
하루 거래량:
606.10K
Relative Volume:
0.03
시가총액:
$21.53M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-5.37%
1개월 성능:
-3.64%
6개월 성능:
-74.15%
1년 성능:
-88.40%
1일 변동 폭
$0.509
$0.5334
1주일 범위
$0.4917
$0.6014
52주 변동 폭
$0.461
$5.1589
Scienture Holdings Inc Stock (SCNX) Company Profile
명칭
Scienture Holdings Inc
전화
(800) 261 0281
주소
20 AUSTIN BLVD., COMMACK
SCNX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SCNX
Scienture Holdings Inc
|
0.53 | 21.24M | 0 | 0 | 0 | 0.00 |
|
HITI
High Tide Inc
|
2.55 | 218.65M | 376.07M | -22.41M | 18.73M | -0.298 |
|
PETS
Petmed Express Inc
|
3.35 | 72.66M | 270.52M | -6.08M | 17.42M | -0.2944 |
|
RDGT
Ridgetech Inc
|
2.54 | 43.15M | 119.97M | -1.45M | 632.50K | -0.9847 |
|
WGRX
Wellgistics Health Inc
|
0.4057 | 41.76M | 28.99M | -39.20M | -3.34M | 0.00 |
|
POM
Pomdoctor Ltd Adr
|
0.3012 | 36.52M | 0 | 0 | 0 | 0.00 |
Scienture Holdings Inc 주식(SCNX)의 최신 뉴스
Aug Spikes: Is EHTH stock forming a cup and handleOil Prices & Free Accurate Trade Setup Notifications - baoquankhu1.vn
EXCLUSIVE: Penny Stock Scienture's Partner Secures US Patent For Highest Dosage Naloxone Spray For Emergency Opioid Overdose Treatment - Sahm
Scienture receives patent for high-dose naloxone nasal spray By Investing.com - Investing.com Nigeria
Head to Head Review: Scienture (NASDAQ:SCNX) & Aldeyra Therapeutics (NASDAQ:ALDX) - Defense World
Scienture And Summit's REZENOPY Awarded Orange Book-Listable Patent, Valid Till 2041 - Nasdaq
SCNX Secures Patent for REZENOPY Nasal Spray Until 2041 - GuruFocus
Scienture receives patent for high-dose naloxone nasal spray - Investing.com
SCIENTURE Announces Issuance of Orange Book-Listable Patent Covering REZENOPY™, the Highest Dosage Naloxone HCl Nasal Spray Approved by the FDA for Life-Saving Opioid Overdose Emergency Treatment - The Manila Times
New patent backs 10 mg naloxone spray for life-saving overdose treatment - Stock Titan
AI Stocks: Will Scienture Holdings Inc stock outperform international peersPortfolio Gains Report & Community Verified Swing Trade Signals - Bộ Nội Vụ
Aug PreEarnings: Will Escalade Incorporated stock hit new highs in YEAR - baoquankhu1.vn
MSN Money - MSN
Scienture Holdings Inc (SCNX) - MSN
Scienture Holdings Inc. (SCNX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Scienture Holdings, Inc.Common Stock (NQ: SCNX - FinancialContent
How buybacks impact Scienture Holdings Inc. stock valuePortfolio Update Summary & Weekly Sector Rotation Insights - Улправда
MarketsMedicine Hat News - FinancialContent
Activity Recap: How buybacks impact Scienture Holdings Inc. stock value2025 Earnings Impact & Daily Chart Pattern Signals - Улправда
Will Scienture Holdings Inc. stock beat EPS estimatesJobs Report & Weekly Watchlist of Top Performers - Улправда
Is Scienture Holdings Inc. stock resilient to inflation2025 Major Catalysts & Weekly Momentum Picks - Улправда
How Scienture Holdings Inc. stock reacts to inflationary pressuresTrade Analysis Summary & High Yield Equity Trading Tips - ulpravda.ru
Why Scienture Holdings Inc. (4E4) stock is favored by hedge funds2025 Major Catalysts & Smart Investment Allocation Tips - ulpravda.ru
Will Scienture Holdings Inc. stock split again soonMarket Growth Report & Real-Time Market Sentiment Reports - ulpravda.ru
Will Scienture Holdings Inc. stock recover faster than peersPortfolio Value Report & Technical Buy Zone Confirmations - ulpravda.ru
Why Scienture Holdings Inc. stock is trending among retail tradersMean Reversion Trades & Explosive Growth Opportunities - Улправда
Will Scienture Holdings Inc stock beat EPS estimates2025 Pullback Review & Weekly Return Optimization Alerts - moha.gov.vn
Scienture Holdings, Inc. (SCNX) - Zacks Investment Research
Scienture Prepares Launch Of REZENOPY, Its Highest-Strength Naloxone Nasal Spray - Nasdaq
SCIENTURE Provides Update on the Commercial Launch of REZENOPY®, the Highest Strength Naloxone HCl Life-Saving Opioid Overdose Emergency Treatment Approved by the FDA - The Globe and Mail
Scienture to launch high-strength naloxone nasal spray in Q2 2026 - Investing.com Nigeria
Is Scienture Holdings Inc stock near bottom after declineJuly 2025 Analyst Calls & Safe Capital Growth Stock Tips - moha.gov.vn
Scienture (SCNX) Advances with REZENOPY Nasal Spray Launch - GuruFocus
Scienture to launch high-strength naloxone nasal spray in Q2 2026 By Investing.com - Investing.com South Africa
Scienture provides update on the commercial launch of Rezenopy - marketscreener.com
Scienture Provides Update On The Commercial Launch Of Rezenopy - TradingView — Track All Markets
New 10 mg overdose nasal spray set to reach U.S. market in 2026 - Stock Titan
Is Scienture Holdings Inc. stock a top momentum playPortfolio Performance Summary & Low Drawdown Investment Strategies - Улправда
Will Scienture Holdings Inc. (4E4) stock announce a stock split2025 Retail Activity & Precise Swing Trade Alerts - Улправда
How Scienture Holdings Inc. stock trades during market volatility2025 Technical Overview & Precise Swing Trade Alerts - Улправда
Scienture Holdings Inc (SCNX) 재무 분석
Scienture Holdings Inc (SCNX)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.20%
1.70%
자본화:
|
볼륨(24시간):